What is an arteriovenous malformation (AVM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is an Arteriovenous Malformation (AVM)?

An arteriovenous malformation is an abnormal tangle of blood vessels that creates a direct connection between arteries and veins, bypassing the normal capillary bed and resulting in high-flow arteriovenous shunting of blood. 1

Structural Definition

AVMs are direct connections of artery to vein via abnormal dilated vascular channels without a normal intermediary capillary bed, creating a high-flow, low-resistance shunt between the arterial and venous systems. 1, 2

  • The abnormal dilated vascular channels are known as the nidus, which represents the core tangle of dysplastic vessels 1, 3
  • This pathological arteriovenous shunting fundamentally alters hemodynamics by allowing blood to bypass the capillary network entirely 2, 4
  • The absence of the normal capillary bed means blood flows directly from high-pressure arteries into low-pressure veins, creating a fast-flow lesion 1

Diagnostic Gold Standard

Four-vessel cerebral contrast angiography is the diagnostic gold standard for brain AVMs, demonstrating the arteriovenous shunting with high spatial and temporal resolution. 1

  • Cervicocerebral angiography remains the reference standard for imaging cerebrovascular AVMs, providing critical characterization of feeding vessels, nidus architecture, and venous drainage patterns 1, 2
  • MRI typically shows an inhomogeneous signal void on T1- and T2-weighted sequences, often with hemosiderin deposits suggesting prior hemorrhage 5
  • Doppler ultrasound demonstrates the hallmark finding of fast-flow with arterialized venous waveforms, distinguishing AVMs from other vascular lesions like venous varices 2

Key Distinguishing Features from Other Vascular Lesions

AVMs must be distinguished from other vascular anomalies based on their high-flow characteristics and direct arteriovenous connection. 1, 2

  • AVMs are not cavernous malformations, dural arteriovenous fistulas, venous malformations, venous varices, or vein of Galen malformations 1
  • Unlike venous varices (which are simply dilated veins), AVMs demonstrate high-velocity arterialized flow on Doppler evaluation 2
  • AVMs are classified as vascular malformations (abnormal vessel formation) rather than vascular tumors (true neoplasms with increased mitotic activity) 1

Clinical Presentation and Natural History

Brain AVMs most commonly present with hemorrhage (50-60% of cases, >75% in children), representing the primary cause of mortality and morbidity. 6

  • The annual hemorrhage risk is approximately 1-3% per year for previously unruptured brain AVMs 5, 6, 3
  • After initial rupture, the hemorrhage risk increases fivefold to 4.8% annually 1, 6
  • Mortality from first hemorrhage ranges 10-30%, with 10-20% of survivors experiencing permanent disability 5, 6
  • Other presentations include seizures, focal neurological deficits, or incidental discovery on imaging 1

Location and Prevalence

AVMs can occur in multiple organ systems, with brain and pulmonary locations being most clinically significant. 1

  • The asymptomatic prevalence of brain AVMs on MRI is estimated at 0.05% 1
  • Pulmonary AVMs occur in 70-90% of patients with hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disorder 5, 6
  • Between 10-20% of HHT patients will develop at least one AVM during their lifetime 1, 2
  • Soft tissue AVMs represent approximately 8% of all vascular malformations 1

Risk Factors for Hemorrhage

Prior hemorrhage is the strongest predictor of future bleeding in patients with AVMs. 5, 6

  • Small AVM size paradoxically increases hemorrhage risk 5, 6
  • Presence of intranidal aneurysms significantly elevates rupture risk 1, 5, 6
  • Deep venous drainage patterns and deep location (periventricular or intraventricular) increase hemorrhage risk 1, 5, 6
  • Venous outflow obstruction is associated with higher bleeding rates 1

Associated Conditions

The majority of pulmonary AVMs (70-90%) are associated with hereditary hemorrhagic telangiectasia. 5, 6

  • HHT type 1 (endoglin mutation) presents with cerebral and pulmonary AVMs 6
  • HHT type 2 (ALK1 mutation) presents with pulmonary hypertension and hepatic AVMs 6
  • Multiple AVMs in different organ systems strongly suggest hereditary HHT rather than sporadic disease 2
  • Other causes of AVMs include trauma, surgery, certain infections, and hepatopulmonary syndrome 5

Common Pitfalls

Never perform liver biopsy in patients with proven or suspected HHT due to catastrophic hemorrhage risk from hepatic vascular malformations. 2

  • Pregnancy dramatically increases the risk of AVM hemorrhage due to hormonal and hemodynamic changes, requiring heightened surveillance 5, 6
  • 25-58% of patients are completely asymptomatic before catastrophic complications occur, emphasizing the critical importance of screening in high-risk populations 6
  • Vessel loops and infundibular origins can lead to false-positive diagnoses of AVMs on MRA 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vascular Lesions: Arteriovenous Malformations and Venous Varices

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Brain arteriovenous malformations.

Nature reviews. Disease primers, 2015

Research

Arteriovenous malformations.

Seminars in pediatric surgery, 2014

Guideline

Stable Right Upper Lobe Arteriovenous Malformation (AVM)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Arteriovenous Malformations Clinical Presentation and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.